FDA-Approved Hydrogel-Mediated In Situ Sonodynamic and Chemotherapeutic Therapy for Pancreatic Cancer
Jian Wang, Nianhui Yu, Yunpeng Tang, Yingsheng Cheng, Hui Li, Hirofumi Hanaoka · 2024
Read FDA-Approved Hydrogel-Mediated In Situ Sonodynamic and Chemotherapeutic Therapy for Pancreatic Cancer by Jian Wang, Nianhui Yu, Yunpeng Tang, Yingsheng Cheng, Hui Li, Hirofumi Hanaoka (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11678859.txt.
Description
Jian Wang and co-authors built a gel-based treatment for pancreatic cancer in 2024 that joins sound-based therapy with drug therapy at the tumor site. A known drug wrapped in albumin helps in advanced cases, but it spreads through the body, clears fast, and can cause harsh side effects. The team sought a local way to hold the drug where it is needed.
They bound the drug and a light-like agent to albumin to form tiny particles, then set those particles in a gel that breaks down in the body. Lab tests checked how stable the mix was and how fast the drug leaked out. Cell and animal work then gauged how well the joint therapy killed cancer. Readers get a design that aims for stronger local effect with less whole-body harm.
Catalog record
| CREATOR | Jian Wang, Nianhui Yu, Yunpeng Tang, Yingsheng Cheng, Hui Li, Hirofumi Hanaoka |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |